Initial reports have suggested that human parvovirus B19 infection in immune-compromised individuals may cause prolonged or chronic bone marrow suppression. We report four children receiving cancer chemotherapy who developed atypical patterns of cutaneous and hematologic disease associated with parvoviral infection. B19 infection was demonstrated by specific serologies. This report suggests that patients undergoing myelosuppressive or immunosuppressive therapy may have unusual manifestations of infection and be at risk for complications associated with this common and widespread pathogen.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
b19 infection
12
parvovirus b19
8
receiving cancer
8
cancer chemotherapy
8
infection
5
infection patients
4
patients receiving
4
chemotherapy expanding
4
expanding spectrum
4
spectrum disease
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!